Stock rally ignites gains in pot stocks while Senate OK's bill language to allow VA doctors to recommend cannabis in legal states
Cannabis company stocks joined in with the market rally on Thursday, with big gains throughout most of the sector. Curaleaf Holdings Inc. (CURLF) rose by 4.7%, Verano Holdings Corp. (VRNOF) jumped 5.7%, Green Thumb Industries Inc. (GTBIF) rose 7.1%, Trulieve Cannabis Corp. (TCNNF) moved up by 3.9%, Tilray Brands Inc. (TLRY) rose by 6%, Canopy Growth Corp. (CGC) rose 8.8% and Ascend Wellness Holdings Inc. (AAWH) rose 6.8%. The AdvisorShares Pure U.S. Cannabis ETF (MSOS) rose 4.2% and the ETFMG Alternative Harvest ETF (MJ) rose 5%. Sitting out the rally, Cresco Labs (CRLBF) traded unchanged and Ayr Wellness (AYRWF) fell by 2.4%. The U.S. Senate on Wednesday voted 82-15 to approve the Military Construction, Veterans Affairs, and Related Agencies (MilConVA) measure, which includes a provision to permit doctors at the U.S. Department of Veterans Affairs (VA) to recommend medical marijuana to patients living in legal states, as initially reported by Marijuana Moment. The final bill will come after a conference with the House's approved version of the measure, which also contained similar language for VA doctors.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-02-23 1408ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom